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Two distinct types of T cell hybridomas (designated THY,- 1 and Tuva-2) were derived by fusing 
BW5 147 thymoma cells with encephalitogenic T helper cells from Lewis rats. Both subsets required 
MHC-restricted presentation of determinants within the 72-86 peptide sequence of myelin basic 
protein (MBP) as a requisite signal for IL-2 production. Unlike Tuva-1 hybrids, however, THYa- 
2 hybrids required additional accessory cell activities that were mediated by radiosensitive non- 
adherent (RS-NAdh) splenocytes (SPL). In this study, we describe two observations indicating 
that RS-NAdh SPL enable MBP-specific responses of T --2 hybrids by providing subset-specific 
co-stimulatory signals that act independently of antigen recognition pathways. First, RS-NAdh 
SPL were required by THYa- 2 hybrids for MBP-stimulated IL-2 production but were not needed 
when MBP-specific inhibition of hybrid growth was used as an alternative measure of cellular 
activation. Second, PMA and ionomycin induced optimal IL-2 production by both T--l hybrids 
and BW5 147 thymoma cells but only stimulated low or marginal levels of IL-2 production by 
TuyS-2 hybrids. Together, these observations indicate that RS-NAdh SPL were required for the 
specific response of IL-2 production regardless of whether the response was stimulated by antigen 
or by mitogens that bypass initial antigen recognition events. This study thereby provides additional 
evidence that distinct stimulus-response relationships define two T-helper cell lineages in exper- 
imental aUtOiIIImUIIe encephalomyelitis. 0 1992 Academic PI=, Inc. 
INTRODUCTION 
Autoreactive T cells that induce EAE3 are widely studied as a means to gain insight 
into encephalitogenic processes responsible for human demyelinating diseases such 
as multiple sclerosis (1). In Lewis rats, EAE is mediated by CD4+ T-helper cells specific 
for overlapping determinants in the 72-86 region of MBP (2-9). Two subsets of EAE- 
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associated T-helper cells have previously been defined by the observation that separate 
clonotypic specificities were respectively associated with either of two types of T cell 
activity (7, 8). One subset responded to the 72-86 peptide sequence of MBP by ex- 
pressing potent EAE transfer activity even though these T cells did not exhibit any 
detectable antigen-specific in vitro proliferation. Rather, in vitro proliferation to MBP 
was mediated by a clonotypically unique subset of T cells that was also specific for 
determinants within the 72-86 MBP sequence. A similar dichotomy of T-helper subsets 
has been implicated in the uveitogenic response to autoantigens of experimental au- 
toimmune uveoretinitis (EAU) (lo- 13). Namely, major uveitogenic determinants are 
closely associated but nevertheless structurally distinct from dominant “proliferative” 
determinants. 
Differences in the encephalitogenic and proliferative activities of these T cell subsets 
may coexist with subset-specific differences in their requirements for specialized types 
of accessory cell activities. For example, T cells purified from draining lymph nodes 
of MBP-sensitized Lewis rats responded synergistically to IL-l and MBP for optimal 
expression of EAE adoptive transfer activity ( 14). Conversely, T cells mediating in 
vitro proliferation to MBP did not exhibit a similar degree of dependence upon IL- 1. 
Additional evidence for subset-specific accessory cell signals was obtained by studying 
T cell hybrids derived by fusion of murine BW5 147 thymoma cells with an enceph- 
alitogenic population of MBP-specific T-helper cells ( 15). Two distinct subsets of hy- 
brids were found that differed in whether RS-NAdh SPL were required for MBP- 
stimulated IL-2 production. Although both subsets required class II MHC-restricted 
presentation of MBP by adherent APC, T nva-2 hybrids also required an additional 
activity of RS-NAdh SPL that was not required by THYB-1 hybrids. 
The purpose of this study was to test two alternative hypotheses concerning how 
RS-NAdh SPL enabled THYB-2 responses to MBP. The first hypothesis predicts that 
RS-NAdh SPL may provide requisite co-stimulatory signals to Tuva-2 hybrids. Co- 
stimulatory signals act in synergy with physically separate signals from MHC-restricted 
antigens to elicit T cell responses (16, 17). Previous studies have shown that T cell 
clones may have stringent requirements for co-stimulation to mediate certain types 
of responses and exhibit little or no co-stimulatory requirements for other types of 
responses. For example, IL-l is a co-stimulus for antigen-stimulated proliferation of 
murine Th2 type T cells ( 18-20). Nevertheless, IL 1 has much less of an effect upon 
antigen-induced IL-4 production by the same T cells (2 1). Likewise, disruption of co- 
stimulatory molecules by chemical fixation of accessory cells engenders a specific T 
cell deficit in antigen-stimulated IL-2 production that only partially affects other an- 
tigen-dependent responses such as IL-3 and y-IFN production (22). Thus, specialized 
types of co-stimulatory molecules appear to selectively enable specific activities of 
particular subsets of T cells. 
The second hypothesis predicts that RS-NAdh SPL may promote IL-2 production 
by enhancing antigen recognition in T uYB-2 hybrids. According to this hypothesis, 
RS-NAdh SPL may present additional I-A/MBP complexes which are preferentially 
accessible to THYB-2 hybrids. Or perhaps RS-NAdh SPL possess adhesive properties 
that promote cluster formation involving both Tuvn-2 hybrids and antigen-bearing 
APC. Any mechanism promoting apposition of THYB-2 hybrids and APC may dra- 
matically potentiate antigen recognition by T m?r2 hybrids. Unlike the hrst hypothesis, 
the second hypothesis predicts that accessory cell activities that enable antigen rec- 
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ognition would also promote other measures of T cell activation in proportion to that 
of IL-2 production. 
An alternative to the IL2 production response that can be readily studied in T cell 
hybrids involves antigen-induced growth inhibition (23, 24). Because T cell hybrids 
retain the immature characteristics of their thymoma fusion partner, antigenic acti- 
vation results in a cell cycle block and subsequently results in cell death. Antigen- 
induced cell death of T cell hybrids is believed to represent mechanisms of clonal 
deletion by which autoreactive thymocytes are deleted upon recognition of self peptides 
in the thymus. In this study, antigen-induced growth inhibition was chosen as an 
alternative assay for cellular activation because it was considered unlikely that a re- 
sponse unique to the murine fusion parent would be regulated by rat co-stimulatory 
molecules. 
The results of this study indicate that RS-NAdh accessory cells enable antigen- 
evoked IL-2 production by THYB- 2 hybrids through provision of essential co-stimu- 
lation. These co-stimulatory signals were delivered independently of T cell antigen 
receptor transduction of antigen/MHC signals and appeared necessary for both an- 
tigenic and mitogenic stimulation of IL-2 production. These findings provide additional 
evidence that distinct co-stimulatory requirements define parallel T cell response path- 
ways in EAE. 
MATERIALS AND METHODS 
Rats. Lewis rats were obtained from Harlan-Sprague-Dawley (Indianapolis, IN), 
These rats were bred in our animal facility and were 5 to 10 weeks old when used in 
experiments. 
Reagents. Guinea pig (GP) MBP was purified from spinal cords (Pel-Freez, Rogers, 
AR) by standard procedures (25). Two synthetic peptides, 
GP7286:YGSLPQKSQRSQDENPV 
[P8’]GP72-86: Y G S L P Q K S Q R P Q D E N P V, 
were synthesized and purified by the Biomedical Research Core Facilities at the Uni- 
versity of Michigan. Ionomycin was purchased from Calbiochem and PMA was ob- 
tained from Sigma. The OX6 B cell hybridoma line that produces anti-rat I-A mono- 
clonal antibody (mAb) (26) was a generous gift of Dr. Alan Williams (University of 
Oxford, Oxford, England). 
T cell hybridomas. As described previously (27) T cell hybrids were derived by 
fusing MBP-specific T cells from Lewis rats with cells from the BW5 147 murine thy- 
moma. T cell hybrids were passaged every 4 days in RPMI- 1640 medium supplemented 
with 10% heat-inactivated fetal bovine serum (Hyclone), 2 mM glutamine (GIBCO), 
100 pg/ml streptomycin (GIBCO), 100 U/ml penicillin (GIBCO), and 50 @4 2-mer- 
captoethanol (Sigma). 
T cell hybrid responses to MBP as measured by IL-2 production and growth inhi- 
bition. T cell hybrids (2.5-10 X lo4 cells/well) were cultured with 5 X lo5 SPL with 
or without antigen in 96-well microtiter plates. After 18 hr, the cultures were pulsed 
for an additional 6 hr with 1 &i of [3H]thymidine (6.7 Ci/mmole, NEN). The su- 
pematants (100 &well) were transferred into replicate plates and the hybrids were 
then harvested on fiberglass filters to measure [3H]thymidine incorporation. As de- 
scribed by Mosmann (28), IL-2 production was measured in a bioassay in which the 
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tetrazolium salt MTT (Sigma) was used to measure viability and growth of the IG2- 
dependent CTLL cell line. Briefly, CTLL cells (5 X 104/50 &well) were cultured for 
18 hr with supernatants from T cell hybridoma cultures. Then, 20 ~1 (5 mg/ml) of 
MTT was added to each well. Four hours later, 120 ~1 of medium was discarded from 
each well and 100 ~1 of 0.04 N HCl in isopropanol (Baker) was added to dissolve the 
dark blue crystals of the MTT formazan product. The 96-well plates were then read 
at 570 nm on an ELISA reader (Microplate Reader, Bio-Rad). By this procedure, IL- 
2 production and growth inhibition were measured in the same single well cultures. 
Preparation of splenic accessory cells. SPL were obtained from untreated Lewis rats 
and were washed twice in Hanks’ balanced salt solution (HBSS). Then, designated 
aliquots of SPL were exposed to a source of r-irradiation ( 1500 or 3000 rads, MARK 
IV irradiator). To obtain the adherent fraction, SPL were aliquoted into 96-well plates 
and incubated in culture medium for 2 hr. Nonadherent SPL were removed by vig- 
orously washing the plates three times with HBSS. Adherent cells remained firmly 
attached to the bottom of the wells and were judged to be macrophages by phase 
contrast microscopy. 
RESULTS AND DISCUSSION 
Two subsets of MBP-specific hybrids defined by d$erent accessory cell requirements. 
Previous research ( 15) has shown that the THY*-2 and THYa- 1 subsets are respectively 
represented by the LSS-C 1 and LSS-D 1 hybrids. As shown in Fig. 1, the THYB-2 hybrid 
was distinguished from the THYB-1 hybrid by its requirement for a unique type of 
accessory cell activity (bottom panel). This accessory cell activity was greatly diminished 
by pretreatment of SPL with y-irradiation (3000 rads) and was virtually eliminated 
by removal of the nonadherent cell fraction (bottom panel). The loss of this accessory 
cell activity did not involve a deficit in antigen presentation because the TnyB- 1 hybrid 
responded similarly to GPMBP when cultured with either SPL, irradiated SPL, or 
irradiated adherent SPL (top panel). Nor was it likely that this loss of accessory cell 
activity reflected limiting IL1 production, because cell types that produce IL-1 (ad- 
herent macrophages) were not depleted from these cultures. In the same experiment, 
two other THYB-1 hybrids and four other THYa- 2 hybrids exhibited the distinctive 
response profiles of the LSS-Dl and LSS-Cl hybrids, respectively. This experiment 
revealed that accessory cell activities of RS-NAdh SPL are optimally measured by 
comparing the activity of normal SPL with that of irradiated adherent SPL. 
Growth inhibition of T cell hybridomas. Like mouse-mouse T cell hybrids, these 
rat-mouse T cell hybrids also exhibited growth inhibition when exposed to GPMBP 
(Fig. 2). The spontaneous proliferation by 11 hybrids was inhibited upon presentation 
of GPMBP by splenic APC (Fig. 2 legend). Furthermore, inhibition of hybrid growth 
was proportional to the stimulation of IL-2 production. To test whether GPMBP 
nonspecifically inhibited hybrid proliferation, similar experiments were also performed 
with synthetic peptide GP72-86 which represents amino acid residues 72-86 of the 
encephalitogenic GPMBP sequence (Fig. 3). This peptide also inhibited hybrid growth 
at concentrations that induced proportional levels of IL-2 production. Neither GPMBP 
nor GP72-86 inhibited proliferation of BW5 147 cells or of T cell hybrids cultured in 
the absence of splenic APCs (M. D. Mannie, unpublished observations). 
Two additional types of experiments were performed to assess whether IL-2 pro- 
duction and growth inhibition represented responses evoked by the same antigen 
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FIG. 1. The THYr,- 1 and Tu,2 subsets of T cell hybrids have different requirements for RS-NAdh SPL. 
The LSS-Dl and LSS-C 1 hybrids are representative of the THYB- 1 and THYB-2 subsets, respectively. These 
hybrids (lO’/well) were cultured for 24 hr with different concentrations of GPMBP and either SPL (5 X 
105/well), irradiated SPL (3000 rads, 5 X 10s/well), or irradiated adherent SPL. Supematants were then 
transferred to replicate plates, and IL-2 activity was measured by the MTT assay of CTLL viability. These 
results represent three experiments. 
recognition events. First, a mAb specific for rat I-A molecules (0X6) was used to 
block T cell responses to GPMBP. This mAb specifically reversed GPMBP-induced 
growth inhibition as measured by a concentration-dependent enhancement of hybrid 
proliferation but did not affect the growth of hybrids cultured in the absence of GPMBP 
(left two panels of Fig. 4). Thus, OX6 specifically reversed GPMBP-induced growth 
inhibition. The concentration dependence of this blockade was similar to that for 
GPMBP-induced IL-2 production (two right panels of Fig. 4). These results indicate 
that same type of MHC-restricted antigen recognition event induces both growth in- 
hibition and IL-2 production. 
Second, antigenic competition experiments were performed to assess whether com- 
petitive inhibition of antigen recognition would reverse growth inhibition as well as 
IL-2 production (Fig. 5). The LSS-Al hybrid exhibited potent reactivity to GP72-86 
but did not respond to [P8’]GP72-86 even though the two peptides differ only by a 
single prolines for serinesO substitution. Rather, [P8’]GP72-86 competitively inhibited 






FIG. 2. GPMBP inhibits spontaneous proliferation of T cell hybrids and proportionally stimulates IL2 
production. T cell hybrids (2.5 X 104/well) were cultured with SPL (5 X lO’/well) and with different con- 
centrations of GPMBP. These cultures were pulsed with 1 &i of [‘Hlthymidine during the last 6 hr of a 
24.hr culture. The supematants were transferred to replicate plates, and the hybrids were then harvested on 
fiberglass filters to measure [3H]thymidine incorporation by scintillation counting. The supematants were 
assayed for IL-2 activity by the MTT assay of CTLL viability (see Materials and Methods). Solid lines and 
dashed lines respectively represent responses of THYB- 1 and T--2 hybrids. Eleven hybrids were assayed in 
this experiment even though the results from only three are presented. The percentage of antigen-specific 
growth inhibition as well as the corresponding production of IL-2 (as measured by OD units from the MTT 
assay) for each hybrid was LSP-Al, 59% (0.633); LSP-AZ, 73% (0.658); LAS-Al, 55% (0.643); LSS-Al, 76% 
(0.673); LSS-B2, 62% (0.720); LSS-B3, 53% (0.545); LSS-Cl, 55% (0.456); LSS-C2, 56% (0.662); LSS-DI, 
43% (0.7 11); LSS-D2,65% (0.347), and LSS-D3, 87% (0.470). These results represent four experiments. 
recognition of GP72-86 by LSS-Al hybrids. Other studies (29) have shown that the 
mechanism of inhibition may involve competitive interactions for peptide binding 
sites on I-A molecules. As shown in Fig. 5, concentrations of [P*‘]GP72-86 that com- 
petitively blocked IL-2 production also blocked the response of growth inhibition in 
a proportional manner. These results provide additional evidence that both types of 
response are elicited by the same type of antigen recognition event. 
Co-stimulatory signals are requiredfor IL-2 production but not growth inhibition of 
TH,2 hybrids. To assess how accessory cells promoted THYB-2 responses to MBP, 
IL-2 production and growth inhibition were assayed in the presence or in the absence 
of RS-NAdh SPL (Table 1). Hybrids cultured with nonfractionated SPL responded 
to GPMBP by producing IL-2 while also exhibiting growth inhibition. Both hybrid 
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FIG. 3. The encephalitogenic peptide GP72-86 also inhibits hybrid growth and proportionally stimulates 
IL-2 production. As described in the legend of Fig. 2, five hybrids were cultured with SPL and with different 
concentrations of GP72-86. Hybrid growth was measured by [3H]thymidine incorporation and IL-2 production 
was measured by the MTT assay of CTLL viability. Solid lines and dashed lines respectively represent 
responses of THYa- 1 and Tnva-2 hybrids. These results represent two experiments. 
subsets also exhibited GPMBP-specific growth inhibition when cultured with irradiated 
adherent SPL. In the latter cultures however, GPMBP exclusively stimulated IL-2 
production by THYB-1 hybrids but not by T nya-2 hybrids. Thus, responses of IL-2 
production and growth inhibition by the same clone in the same culture were disso- 
ciated based upon differential accessory cell requirements. 
Nor did the dissociation of growth inhibition from IL-2 production reflect a small 
quantitative difference within a narrow set of experimental conditions. Rather, this 
dissociation was observed across a wide range of adherent cell densities (Fig. 6) and 
GPMBP concentrations (Fig. 7). The interpretation most consistent with these data 
is that RS-NAdh SPL provide co-stimulatory signals necessary for MBP-induced IL- 
2 production by THYB-2 T cell hybrids. 
The differential co-stimulatory requirements of THYB- 1 and THYB-2 hybrids did not 
correlate with any consistent quantitative difference in response parameters such as 
the potency or magnitude of the IL-2 response that could be detected in the presence 
of nonfractionated SPL (27). Nor did the requirement for co-stimulation correlate 
with differential expression of rat CD2, CD4, CD8, CD45, Thy-l, or IL-2 receptor 
proteins by T cell hybrids (M. D. Mannie, unpublished observations). Rather, these 
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FIG. 4. Concentrations of anti-rat I-A mAb that block GPMBP-specific growth inhibition are similar to 
those that block GPMBP-stimulated IL-2 production. Designated hybrids and SPL were cultured with different 
concentrations of the OX6 mAb for 1 hr, and then 2 ph4 GPMBP was added to designated wells. Hybrid 
proliferation and IL2 production were measured as described under Materials and Methods. These results 
represent four experiments. 
subset-specific differences in co-stimulatory requirements are attributed to qualitative 
differences in the molecular physiology of T cell activation pathways leading to IL-2 
production. 
However, additional experiments were needed to establish that these subset-specific 
differences reflected differential co-stimulatory requirements rather than differential 
production of co-stimulatory molecules. According to the latter possibility, both subsets 
may share the same requirements for co-stimulation with the subset-specific differences 
instead reflecting autologous production of co-stimulatory molecules by THYB- 1 hybrids 
but not by THYB- 2 hybrids. If so, then THYB-1 hybrids would provide co-stimulatory 
signals that would fulfill the activation requirements of THYB-2 hybrids. To test this 
possibility, a THYB- 1 hybrid (LSS-D 1) and a T nYB-2 hybrid (LSP-A 1) were co-cultured 
together with irradiated adherent APCs and the peptide [Ps0]GP72-86 (Table 2). This 
antigen specifically stimulates the T nue-2 hybrid but is not recognized by the THYB- 1 
hybrid. Under these experimental conditions, the THYB-2 will not produce IL-2 due 
to the lack of a co-stimulus unless the co-stimulus is provided by the THYB-1 hybrid. 
As shown in Table 2, the THYB-2 hybrid responded to [Ps0]GP72-86 when cultured 
with SPL but not when cultured with irradiated adherent APCs. Furthermore, the 
addition of THYB-1 hybrids to these cultures did not reconstitute the co-stimulatory 
signal. These results provide further evidence that the two subsets differ in their re- 
quirements for co-stimulation. 
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FIG. 5. [P8’]GP72-86 competitively inhibits GP72-86-stimulated IL-2 production and concomitantly re- 
verses GP72-86-induced growth inhibition. Antigenic competition was used as a means to determine whether 
the hybrid responses of IL-2 production and growth inhibition were dependent upon the same antigen 
recognition events. The LSS-A1 hybrid (5 X 104/well) was cultured with SPL (5 X lO’/well) and different 
concentrations of GP72-86 in the presence of either 0, 1, 10, or 32 M of [p8’]GP72-86 for 24 hrs. Hybrid 
growth inhibition and IL-2 production were respectively measured by [3H]thymidine incorporation and by 
the MTT assay of CTLL viability. In the same experiment, similar results were obtained for the LSS-Dl 
hybrid. These results represent three experiments. 
Mitogenic responsiveness 0fT HyFl and THyB2 subsets. The studies described above 
showed that the pathway leading to IL2 production in THYB-1 hybrids differs from 
that in Tnva-2 hybrids. However, the molecular nature of this difference has yet to be 
defined. To gain insight into this question, we hypothesized that regulatory mechanisms 
selectively expressed within T nYB-2 hybrids may act to repress a pivotal intracellular 
mediator in the cascade of intracellular events leading to IL-2 production. To address 
this question, THYB-2 hybrids were cultured with PMA and ionomycin to determine 
whether mitogenic signals as opposed to antigenic signals would suffice to elicit IL-2 
production in the absence of co-stimulation. The mitogenic combination of PMA and 
ionomycin was chosen for these studies because these compounds are known to re- 
spectively elicit protein kinase C activation and Ca” influx. These events synergistically 
induce cellular activation and lymphokine production (30). PMA and ionomycin are 
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TABLE 1 
Tu,-2Specific Co-stimulatory Factors Required for GPMBP-Stimulated IL-2 Production 
Are Not Required for GPMBP-Induced Growth Inhibition 
Percent maximal growth inhibition:“ 
Hybrid [and subset] In culture 
designation b with SPL 
In culture with 







64% 79% 61% 
47% 16% 92% 
52% 51% 2% 
63% 61% 5% 
55% 56% 9% 
55% 60% 1% 
a Hybrids were cultured with either SPL or irradiated adherent SPL (IRRADH) in the presence or absence 
of GPMBP for 24 hr. [3H]thymidine incorporation and IL-2 production were measured as described under 
Materials and Methods. GPMBP-induced percent inhibition of hybrid growth was defined as 1 minus the 
ratio of mean cpm from triplicate wells with 1 @M GPMBP to mean cpm of triplicate wells without GPMBP. 
b The hybrid designations have been previously described (12). Subset designations [I] and [2] respectively 
refer to the THYB- 1 and T--2 subsets. 
’ Percent maximal IL-2 production was defined as mean OD values from triplicate wells with GPMBP/ 
IRRADH SPL divided by the mean OD values from triplicate wells with GPMBP/SPL. Mean OD values 
from hybrids and SPL cultured with GPMBP were (from top to bottom): 0.222,0.242,0.159,0.206,0.175, 
and 0.138. Mean OD values obtained from triplicate wells without antigen were subtracted from mean OD 
values from experimental groups. These results represent three experiments. 
also known to elicit IL-2 production by the BW5 147 thymoma fusion parent of these 
hybrids (3 1). Hence, these mitogens would predictably stimulate IL-2 production only 
if the IL-2 production pathway was repressed at a point before rather than after ac- 
tivation of protein kinase C and mobilization of intracellular Ca”. 
As shown in Table 3, THYB-2 hybrids exhibited responses to PMA and ionomycin 
that were low or negligible as compared either to the respective mitogenic responses 
of THYB-1 hybrids or to the antigenic responses (GPMBP + SPL) of THYB-2 hybrids. 
Furthermore, these subset-specific differences in mitogenic activity represented large 
differences in optimal levels of IL-2 production rather than quantitative differences 
of sensitivity to different mitogen concentrations (Fig. 8). The TnYB-2 hybrids also 
lacked normal mitogenic responsiveness as compared to the BW5 147 thymoma parent 
cell line. In five additional experiments, the response of BW5 147 thymoma cells and 
LSP-A2 hybrids (T uYB-2) to PMA and ionomycin respectively averaged 92 and 26% 
of the response exhibited by LSS-A 1 hybrids (T HUB- 1). These experiments also revealed 
that low levels of apparent IL-2 production by LSP-A2 were attributed to the carry- 
over of PMA and ionomycin which promoted viability and growth of CTLL cells. 
These latter findings support the possibility that T nYB-2 hybrids may not produce any 
IL2 in response to PMA and ionomycin. Overall, these findings are consistent with 
the concept that (a) IL-2 production pathways are repressed in THYB-2 hybrids and 
(b) co-stimuli from RS-NAdh SPL act to restore critical events in IL-2 production 
pathways subsequent to the generation of signals for protein kinase C activation or 
Ca’+ influx. 
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FIG. 6. The dissociation of growth inhibition from IL-2 production was apparent across a wide range of 
adherent cell densities. Monolayers of irradiated adherent SPL were isolated by incubating irradiated SPL 
for 2 hr in complete RPM1 medium at densities of 2 X 106, 1 X 106, 5 X lo’, 2.5 X IO’, 1.25 X 105, 6 X 
104, or 0 cells/well. Nonadherent cells were removed by washing the wells three times with HBSS. T cell 
hybrids (2.5 X 104/well) were added to these wells and were cultured with or without 1 pJ4 GPMBP. As 
described under Materials and Methods, the growth inhibition was measured by [3H]thymidine incorporation 
and IL-2 production was measured by the MTT assay of CTLL growth. Percent decrease in [‘Hlthymidine 
incorporation was defined as 1 minus the ratio of mean cpm from triplicate wells with GPMBP and irradiated 
adherent SPL to the mean cpm of corresponding triplicate wells with GPMBP but without irradiated adherent 
SPL. The percentage of maximal IL-2 production was defined as mean OD values from triplicate wells with 
GPMBP and irradiated adherent SPL divided by the mean OD values from triplicate wells with GPMBP 
and SPL. Solid lines and dashed lines respectively represent responses of Tn,-1 and THvr,-2 hybrids. These 
results represent two experiments. 
Co-stimulatory molecules ofRS-NAdh SPL are distinct fvom IL-l. Research into the 
activation requirements of mouse-mouse T cell hybridomas has led to the view that 
hybrids do not exhibit the co-stimulatory requirements of their normal T cell counter- 
parts (32, 33). However, the results presented herein show that rat-mouse T cell hy- 
bridomas can be used to study at least certain types of co-stimulatory signals required 
by at least one CD4+ T-helper subset. Hence, whether T cell hybrids can be used to 
study co-stimulatory pathways may reflect species variations, the subset of T cell used 
to derive the hybridomas, and the types of co-stimulatory molecules under study. 
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PIG. 7. The dissociation of growth inhibition from IL-2 production was apparent across a wide range of 
GPMBP concentrations. Irradiated monolayers of adherent SPL were prepared by incubating 2 X 106 irradiated 
SPL/well for 2 hr in 96-well plates. The nonadherent fraction was then removed by washing three times in 
HBSS. Adherent SPL and the designated hybrids were cultured with different concentrations of GPMBP 
for 24 hr to measure growth inhibition and IL2 production. Percent decrease in [3H]thymidine incorporation 
was defined as 1 minus the ratio of mean cpm from triplicate wells with GPMBP to the mean cpm of 
triplicate wells without GPMBP. The percentage of maximal IL-2 production was defined as mean OD units 
from triplicate wells with GPMBP and irradiated adherent SPL divided by the mean OD units from triplicate 
wells with GPMBP and SPL. Solid lines and dashed lines respectively represent responses of T--l and 
T--2 hybrids. These results represent three experiments. 
For example, IL-l has been shown to be an important co-stimulator of encephali- 
togenic T cells ( 14). After derivation of the hybrids described in this study, experiments 
were performed to determine whether the hybrids retained the IL 1 reactivity of their 
parent MBP-specific T cells. Again, two types of hybrids were found based upon their 
differential reactivity to IL-1 (Table 4). In the presence of irradiated thymocytes, 
GPMBP stimulated high levels of IL-2 production by four hybrids and substantially 
lower levels of IL-Z production by seven other hybrids. The addition of exogenous IL- 
1 had little or no effect upon the former group of hybrids. In the latter group of hybrids, 
however, exogenous IL-1 acted in concert with GPMBP to promote IL-2 production 
by six of seven hybrids. This was a paradoxical observation, because T cell dependency 
on IL- 1 is usually observed only when IL 1 producing APC are not included in the 
culture ( 14). Possibly, IL- 1 was not produced in sufficient concentrations by irradiated 
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TABLE 2 
T -- 1 Hybrids Do Not Provide Co-stimulatory Signals to T--2 Hybrids” 
Accessory 
Cells 
IL-2 production elicited by (Mean OD values)b 
T --2 hybrid T uYB-l hybrid GPMBP [p8’]GP72-86 
SPL LSP-A2 - 0.210 0.214 
IRRADH LSP-A2 - 0.014 0.006 
IRRADH - LSS-D 1 0.377 0.000 
IRRADH LSP-A2 LSS-D 1 0.392 0.018 
IRRADH - LSS-A 1 0.353 0.003 
IRRADH LSP-A2 LSS-A 1 0.376 0.023 
n Designated types of accessory cells were cultured with T--2 hybrid cells, with Tuva- 1 hybrid cells, or 
with both types of hybrids together. After 24 hr of culture, IG2 production was measured from each well 
as described under Materials and Methods. Similar results were also obtained in an additional experiment 
in which the LSP-A 1 hybrid was mixed with either the LSS-A 1 hybrid or the LSS-DI hybrid. 
b Mean OD values are from triplicate wells with 2 PM GPMBP or 1 ~IV [p]GP72-86. 
thymocytes to optimally stimulate this latter group of hybrids. Alternatively, these 
hybrids may have lost the capacity to trigger IL-l production by these APC. 
The IL 1 responsive and IL 1 nonresponsive hybrids were subsequently characterized 
as THYB-2 and THYB- 1 subsets based upon their differential requirement for RS-NAdh 
accessory cells. However, IL- 1 responsiveness was lost during long-term in vitro prop- 
agation and recloning of the Tuva-2 hybrids. The experiment presented in Table 4 
was the second of six experiments sequentially performed within a 2-year period in 
which the proportion of continuously propagated THYB-2 hybrids exhibiting IL-I re- 
TABLE 3 
Differential Mitogen Sensitivity of THYB- 1 and T--2 Hybrids 
Hybrid (and subset) 
designation 
Percent maximal IL-2 production by PMA + ionomycin-stimulated 
hybrids (OD from hybrids cultured with SPL + GPMBP) 

































’ T cell hybrids (2.5 X lO“/well) were cultured either with 5 X 10’ SPL/well and 1 N GPMBP or with 
2 pM ionomycin and 60 nM PMA. Supernatants were then tested for IL-2 content by the MTT assay of 
CTLL viability. Percent maximal IL2 production was defined as mean OD values from triplicate wells with 
60 nM PMA + 2 & ionomycin divided by the mean OD values from triplicate wells with 2 PM GPMBP 
+ SPL. 
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FIG. 8. T hybrid subsets can also be distinguished by differences in mitogenic responsiveness to PMA and 
ionomycin. T cell hybrids or BW5147 cells (2.5 X 104/well) were cultured with designated concentrations 
of ionomycin and PMA for 24 hr. IL-2 production was assayed by the MTT assay of CTLL growth. LSS- 
A 1 and LSP-A2 are THYB- 1 and T--2 hybrids, respectively. 
sponsiveness was 212, 6/l, 218, O/8, O/8, and O/3, respectively. These hybrids nev- 
ertheless continued to exhibit full responsiveness to GPMBP in the presence of normal 
SPL, indicating that these hybrids retained full reactivity to co-stimulation by RS- 
NAdh SPL. It is not known whether chromosomal loss or other unknown variables 
accounted for this apparent loss of IL-l reactivity. 
These results suggest that IL- 1 and RS-NAdh SPL may provide separate but func- 
tionally related co-stimulatory signals. Even though IL-1 and the cell-associated co- 
stimuli represent distinct signals, it is possible that both may act on MBP-specific T 
cells to fulfill the same co-stimulatory requirement. One possibility is that the two 
different co-stimulators may act to augment T cell responses in different anatomical 
locations or during different phases of the immune response. For example, RS-NAdh 
accessory cells may be the primary physiological mediators of this co-Stimulatory 
activity in lymphoid organs whereas IL-1 may fulfill this requirement in sites of in- 
flammation. 
Subsets of T-helper cells in EAE. Although the role of radiosensitive co-stimuli in 
EAE induction has yet to be defined, three observations suggest a close relationship 
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TABLE 4 
IL- 1 Partially Reconstitutes Responses of Newly Derived T--2 Hybrids 
cpm (X10m3) of [‘Hlthymidine incorporation by 
CTLLs as a measure of IL-2 production by hybrids 
cultured with irradiated thymocytes and” 
Hybrid designation GPMBP + IOU GPMBP + 1OOU Percent maximal increase 
(and subset) GPMBP ILl/ml ILl/ml due to IL1 
LSS-Al (1) 88 93 96 10 
LSS-Dl (1) 98 102 97 4 
LSS-D2 (1) 71 91 89 21 
LSS-D3 (1) 83 94 90 13 
LAS-Al (2) 15 28 21 79 
LSP-Al (2) 16 85 88 454 
LSP-A2 (2) 20 46 45 130 
LSS-B3 (2) 16 33 23 103 
LSS-B4 (2) 5 28 35 595 
LSS-Cl (2) 16 34 40 155 
LSS-c2 (2) 12 9 11 -4 
a T cell hybrids (5 X lO’/well) and irradiated thymocytes (1500 rads, 5 X 105/well) were cultured for 24 
hr with or without GPMBP in the presence or absence of recombinant human IL1 ,f3 (Immunex Corp., 
Seattle). Supernatants were then tested for IL-2 content by measuring proliferation of CTLLs. 
of the co-stimulus-dependent T uYB-2 subset with EAE-inducing T cells. First, MBP- 
sensitized lymph node cells with specificity for the synthetic peptides [P*‘]GP68-84 
and [A75]GP68-84 expressed potent EAE transfer activity even though T cells of this 
specificity were not detected by in vitro proliferative assays (8). This finding indicated 
that these T cell clonotypes expressed encephalitogenic activity rather than proliferative 
activity at this phase of the immune response. Three of twelve hybrids also exhibited 
specificity for either the [A75]GP68-84 peptide (LAS-Al hybrid) or the [Ps0]GP68-84 
peptide (LSP-A 1 and LSP-A2 hybrids). Notably, all three of these hybrids were of the 
Tnva-2 subset. Together, these studies support the concept that the normal counterparts 
of at least some co-stimulus-dependent T nYB-2 hybrids have EAE-inducing activity. 
Second, previous studies have shown that continuously propagated lines of en- 
cephalitogenic T cells have attributes similar to that of THYB-2 hybrids. For example, 
Ben-Nun and Cohen derived a T cell line that responded to MBP in the presence of 
nonfractionated lymphoid cells (5). However, the same T cells did not respond to 
MBP when cultured with the corresponding adherent cell fraction of accessory cells. 
The lack of accessory cell activity by adherent cells had to be reconciled with the 
knowledge that these cells are primarily macrophages active in antigen presentation. 
Like TnYB-2 hybrids, nonadherent accessory cells were apparently required in addition 
to the adherent APCs to support activation of this MBP-specific T cell line. Hence, 
these findings are consistent with the possibility that nonadherent accessory cells may 
provide the same requisite co-stimuli to encephalitogenic T cells as they do for THYB- 
2 hybrids. 
Third, both encephalitogenic T cells and newly derived THYB-2 hybrids were re- 
sponsive to exogenous IL- 1 ( 14) (Table 4). For example, previous research has revealed 
that IL- 1 acts synergistically with MBP to activate expression of EAE transfer activity 
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by MBP-sensitized lymph node cells. In contrast, IL-l was less active in promoting 
in vitro proliferative responses to MBP in parallel cultures. These findings suggest that 
two distinct subsets of MBP-specific T cells can be defined by differential responsiveness 
to IL-l. This IL-1 responsive subset may correspond to the THYB-2 subset because 
newly derived THYB-2 hybrids were also responsive to IL1 as measured by MBP- 
stimulated lymphokine production (Table 4). 
Rather than representing divergent lineages, -the THYB- 1 and THYB-2 subsets may 
represent sequential phases of a given differentiation pathway. Repeated exposure to 
certain types of antigens during immune responses may promote differentiation of 
antigen-specific T cells such that they acquire novel co-stimulatory requirements along 
with specialized effector functions. If true, then the THYB-2 subset may represent dif- 
ferentiated effector T cells that require “help” for clonal expansion and co-stimulation 
for activation of effector functions. Co-expression of stringent co-stimulatory require- 
ments with specialized effector activities may provide a means for immune regulation 
of those effector activities. 
These observations may provide insight into why it has been so difficult to identify 
T cell antigens that cause spontaneous autoimmune disease in experimental animals 
and in humans. This mystery stems from the difficulty in reliably detecting in vitro 
proliferative responses to predicted autoantigens by T cells directly isolated from target 
organs. As exemplified by patients with multiple sclerosis, T cells that are directly 
isolated from blood, from cerebrospinal fluid, or from demyelinating plaques do not 
appear sensitized to CNS antigens as measured by proliferative assays (34,35). In fact, 
the proportion of myelin-specific T cell lines isolated from the peripheral blood of 
multiple sclerosis patients appears similar to their frequency in control individuals 
(36, 37). These findings stand in contrast to other experimental approaches which 
have suggested that disease-specific T cell sensitization to myelin antigens does occur 
in multiple sclerosis (38,39). Even in experimentally induced models of autoimmunity, 
the T cell clonotypes most closely associated with induction of disease appear to lack 
autocrine proliferative activity (7, 8, 10-l 3). In fact, the lack of detectable T cell 
proliferative responses against CNS-specific antigens in multiple sclerosis may be 
mechanistically related to lack of MBP-specific proliferation by rat T cells responsible 
for the adoptive transfer of EAE (7, 8). 
This possibility is supported by the observation that target organs affected in different 
autoimmune diseases such as the cerebrospinal fluid of patients with multiple sclerosis, 
the synovial fluid of patients with rheumatoid arthritis, or peripheral blood of patients 
with systemic lupus erythematosis are populated by T cells lacking normal respon- 
siveness to mitogens (40-43). In a similar manner, an encephalitogenic line of rat T- 
helper cells also was refractory to stimulation with the mitogen Con A even when 
these cells were cultured with splenic macrophages (5). In both cases, mitogenic un- 
responsiveness appears to be due to the lack of appropriate co-stimuli. That is, the 
mitogenic activity of T cells isolated from multiple sclerosis patients was restored with 
PMA (43), and optimal mitogenic responses by the encephalitogenic rat T cell line 
were observed only in the presence of nonfractionated SPL (5). In a similar manner, 
the lack of responsiveness of T HyB-2 hybrids to PMA and ionomycin may be associated 
with their requirement for co-stimulatory molecules on RS-NAdh SPL. 
Likewise, differentiation pathways of autoreactive T cells in multiple sclerosis may 
link upregulation of effector cell activity with downregulation of IL-Zdependent au- 
tocrine proliferation. Accordingly, organs affected in multiple sclerosis and rheumatoid 
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arthritis are primarily populated by T cells expressing the CD4+, CDw29+ “helper- 
inducer” or “memory” phenotype (44-46). Conversely, relatively few of these cells 
express the CD4+, CD45RA+ “naive or suppressor-inducer” phenotype. Fractionation 
of these subsets reveals that the differentiated subset rather than the naive subset is 
refractory to mitogenic stimulation (43). Together, these studies support the view that 
target organs in autoimmune disease contain sequestered populations of effector T 
cells which have differentiated such that their expression of effector activity is coupled 
with the expression of stringent requirements for co-stimulation. 
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